Chinese Environmental Mutagen Society

　　Carcinogenesis, Teratogenesis & Mutagenesis (CTM) is the official Journal of Chinese Environmental Mutagen Society and is undertaken by Shantou University Medical College. It is the source journal for Chinese Scientific and Technical Papers and Citations. The impact factor is 0.379 and ranks fourth among more than 30 Chinese oncologic journals according to Chinese S&T Journal Citation Reports 2003.
It may be worth mentioning that the Journal has been included in 14 Chinese important indexing systems, including CSTPC, CEPS, CJFD, CMCC, CBMDISC, CAJ-CD and so on.
Editorial board of CTM deeply appreciated what you have done for us and looks forward to your further attention and contribution.

　　Carcinogenesis, Teratogenesis & Mutagenesis
Honorary Editor-in-Chief: TAN Jia-zhen
Editor-in-Chief: CHENG Shu-jun
Deputy Editor-in-Chief:
HUANG Tian-hua (Executor) LI Yong LU You-yong WU Yi-min
Director of Editorial Office: HUANG Tian-hua
Editing: Editorial Board of Carcinogenesis, Teratogenesis & Mutagenesis 22 Xinling Road, Shantou, Guangdong, China 515041,
Tel & Fax: 0754-8900267,E-mail:cemsctm@stu.edu.cn
Publishing: Science Press
Distributor: Beijing Post Office in China
Domestic: All Local Post Office in China, Code No. 80-285, Unit price ￥6.00
Overseas Distributor: China International Book Trading Corporation (P.O. Box 399, Beijing 100044, China Code No. 6364 BM), Unit price: USD & 2.00
Printing: Jingmei Color Printing Co., Ltd

Editorial Board

Aims And Scopes

Submission Online

Manuscript Tracking

Instruction for Authors

Copyright Agreement

Editorial Board Office

Editor-in-chief

　　Cheng Shujun is currently as a professor of Cancer Institute (Hospital), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, and Chief Scientist of both China State Key Basic Research Project “Fundamental investigation of human carcinogenesis and cancer therapy and prevention” and Beijing key Cancer Research Project “Tumor biomarker profiling and human cancer diagnosis and therapy”. He worked as a visiting scientist in Laboratoire de Medicine Experimental, Institute de la Recherches Scientifiques sur le Cancer, France (1978-1981), and in Department of Pathology, Medical College of Ohio, USA (1986-1987). He has established a series of short-term tests for the detection of environmental carcinogens and anti-carcinogens in China. He was elected as a Member, Chinese Academy of Engineering in 1999. Dr. Cheng is the President of Chinese Environmental Mutagen Society, and Vice President of China Anticancer Association. He found that the tea catechins showed a significant inhibitory effect against human genital condylomas and inflammatory hyperplasia. Based on the invention, he and his collaborators had received international patents “Composition for treating condyloma acuminate” in 1998. This invention had been approved to go for clinical phase III trial by US FDA. As invited speakers, Dr. Cheng has visited many institutes at foreign countries and attended at international conferences.

Please use 1024×768
Copyright © 2005 editorial office of Carcinogenesis, Teratogenesis & Mutagenesis (CTM)
Address:22 Xin-Ling Road,Shantou,Guangdong,China (515041)
Tel & Fax:0754-8900267,E-mail:cemsctm@stu.edu.cn
Support by Beijing Magtech Co.ltd